Dieldrin‐Induced Mallory Bodies in Hepatic Tumors of Mice of Different Strains

Earl F. Meierhenry, Boris H. Ruebner, M. Eric Gershwin, Lucy S. Hsieh, Samuel W. French – 1 January 1983 – Mallory bodies (MBs) were induced in hepatic tumors by administration for up to 85 weeks of a diet containing 10 ppm dieldrin to 50 C3H/He and 62 C57BL/6J X C3H/He B6C3F1 male mice. MBs were seen in 15 of 28 (54%) mice which developed benign hepatic tumors and 33 of 45 (73%) mice with hepatocellular carcinoma, but in only 3 of 39 (8%) mice without hepatic tumors.

Hepatic Free Fatty Acids in Alcoholic Liver Disease and Morbid Obesity

Peter G. Mavrelis, Helmut V. Ammon, John J. Gleysteen, Richard A. Komorowski, Ursula K. Charaf – 1 January 1983 – Alcoholic liver disease is characterized by the accumulation of fat and inflammatory changes in the liver. Because free fatty acids, the precursors of triglycerides, can damage biological membranes, accumulation of free fatty acids in the liver might be in part responsible for the functional and morphological changes seen in alcoholic liver disease.

Nitroglycerin improves the hemodynamic response to vasopressin in portal hypertension

Roberto J. Groszmann, David Kravetz, Jaime Bosch, Mortom Glickman, Jordi Bruix, James Bredfeldt, Harold O. Conn, Juan Rodes, Edward H. Storer – 1 November 1982 – This study was designed to investigate whether the addition of nitroglycerin to vasopressin infusion could avoid the deleterious systemic effects of vasopressin while maintaining or enhancing the therapeutic benefits of portal pressure reduction. The effect of nitroglycerin on splanchnic and systemic hemodynamics was studied in cirrhotic patients and portal hypertensive dogs receiving i.v. vasopressin. During i.v.

A study of bile canalicular contractions in isolated hepatocytes

M. James Phillips, Chikara Oshio, Mamoru Miyairi, Hart Katz, Charles R. Smith – 1 November 1982 – Living hepatocytes observed under standard methods of cell isolation and culture show frequent active contractions of bile canaliculi when viewed by time‐lapse cinephotomicrography. This report gives details of the methods used to show the contractions. In addition, the characteristics of the contraction pattern are defined and analyzed. The contractions are regular, canalicular contraction time (systole) lasts 60 sec, and the most probable interval between contractions is 5 1/2 min.

Immunofluorescence of phenobarbital inducible cytochrome P‐450 in the hepatic lobule of normal and phenobarbital‐treated rats

Kunihiko Ohnishi, Akihiko Mishima, Kunio Okuda – 1 November 1982 – The localization of the form of cytochrome P‐450 that is induced by phenobarbital was studied by direct immunofluorescence in the hepatocytes of rats pretreated with phenobarbital in comparison with saline‐treated rats. Specific fluorescence was seen in the hepatocyte cytoplasm in saline‐ and phenobarbital‐treated rats; a more concentrated halo of fluorescence was detected surrounding the nuclei in the centrilobular zones after phenobarbital treatment.

Uptake and intracellular disposition of IgA by rat hepatocytes in monolayer culture

Albert L. Jones, Sandra Huling, Gary T. Hradek, Henry S. Gaines, William D. Christiansen, Brian J. Underdown – 1 November 1982 – It is well documented that the liver provides an important source of secretory immunoglobulin A (sIgA) in the gut fluid. In the rat, liver parenchymal cells can actively sequester the dimeric form of IgA (dIgA) from plasma and transfer it attached to its receptor, secretory component (SC), via vesicles into the bile.

Prednisolone in HBsAg‐positive chronic active hepatitis: Histologic evaluation in a controlled prospective study

Pui C. Wu, Ching L. Lai, Kui C. Lam, Joana Ho – 1 November 1982 – To study the value of corticosteroids in HBsAg‐positive chronic active hepatitis, 18 pairs of liver histology comprising 36 liver biopsies from a prospective, randomized, controlled trial were evaluated. The median interval between the initial and follow‐up histology was 8 1/2 months in 8 patients given prednisolone and 8 1/4 months in 10 patients given placebo tablets.

Subscribe to